Literature DB >> 28606403

Diaphragmatic dysfunction in SEPN1-related myopathy.

Serena Caggiano1, Sonia Khirani2, Ivana Dabaj3, Eliana Cavassa3, Alessandro Amaddeo4, Jorge Olmo Arroyo5, Isabelle Desguerre6, Pascale Richard7, Renato Cutrera8, Ana Ferreiro9, Brigitte Estournet10, Susana Quijano-Roy10, Brigitte Fauroux11.   

Abstract

SEPN1-related myopathy (SEPN1-RM) is characterized by predominant axial muscle weakness, early scoliosis, rigid spine and severe respiratory insufficiency. The aim of the study was to characterize the mechanisms of respiratory dysfunction in SEPN1-RM patients. Breathing pattern and respiratory muscle strength were measured by means of esophageal (Pes) and gastric (Pgas) pressures. Seven patients aged 7-55 years (1 adult) at first respiratory muscle test were studied. Five patients were treated by nocturnal noninvasive ventilation (NIV)  ≥ 4 months. Mean ΔPes was within normality during tidal breathing, but the ΔPgas/ΔPes index indicated an increased contribution of the rib cage and expiratory muscles, as compared to the diaphragm, in the pediatric patients and bilateral diaphragmatic paralysis in the adult patient. Forced vital capacity (FVC) was reduced in all patients (52 ± 19%pr) with mean FVC seated-supine drop of 24 ± 7%. Global inspiratory muscle and diaphragmatic strengths were moderately reduced in 2 patients, highly reduced in 4 patients and severely reduced in the adult patient. Expiratory muscle strength was moderately reduced in 6 patients and severely reduced in the adult patient. FVC and respiratory muscle strength remained stable in 2 patients treated by nocturnal NIV within a 3-year follow-up. This study confirms that diaphragmatic dysfunction is a characteristic feature of SEPN1-RM and NIV may stabilize the decline in respiratory muscle strength.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diaphragm; Noninvasive ventilation; Respiratory function; Rigid spine muscular dystrophy; SEPN1-related myopathy

Mesh:

Substances:

Year:  2017        PMID: 28606403     DOI: 10.1016/j.nmd.2017.04.010

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

1.  CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report.

Authors:  Liting Chen; Bin Xu; Wanying Liu; Di Wang; Jinhuan Xu; Xia Mao; Min Xiao; Jianfeng Zhou; Yi Xiao
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

2.  A maladaptive ER stress response triggers dysfunction in highly active muscles of mice with SELENON loss.

Authors:  Diego Pozzer; Ersilia Varone; Alexander Chernorudskiy; Silvia Schiarea; Sonia Missiroli; Carlotta Giorgi; Paolo Pinton; Marta Canato; Elena Germinario; Leonardo Nogara; Bert Blaauw; Ester Zito
Journal:  Redox Biol       Date:  2018-10-26       Impact factor: 11.799

Review 3.  Update on Congenital Myopathies in Adulthood.

Authors:  George Konstantinos Papadimas; Sophia Xirou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

Review 4.  Non-invasive Ventilation in Children With Neuromuscular Disease.

Authors:  Brigitte Fauroux; Sonia Khirani; Lucie Griffon; Theo Teng; Agathe Lanzeray; Alessandro Amaddeo
Journal:  Front Pediatr       Date:  2020-11-16       Impact factor: 3.418

5.  Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathy.

Authors:  Anne Filipe; Alexander Chernorudskiy; Sandrine Arbogast; Ersilia Varone; Rocío-Nur Villar-Quiles; Diego Pozzer; Maryline Moulin; Stefano Fumagalli; Eva Cabet; Swati Dudhal; Maria-Grazia De Simoni; Raphaël Denis; Nathalie Vadrot; Corinne Dill; Matteo Giovarelli; Luke Szweda; Clara De Palma; Paolo Pinton; Carlotta Giorgi; Carlo Viscomi; Emilio Clementi; Sonia Missiroli; Simona Boncompagni; Ester Zito; Ana Ferreiro
Journal:  Cell Death Differ       Date:  2020-07-13       Impact factor: 15.828

6.  Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies.

Authors:  Massimo Ganassi; Francesco Muntoni; Peter S Zammit
Journal:  Exp Cell Res       Date:  2021-11-03       Impact factor: 3.905

7.  The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series.

Authors:  Rocio N Villar-Quiles; Maja von der Hagen; Corinne Métay; Victoria Gonzalez; Sandra Donkervoort; Enrico Bertini; Claudia Castiglioni; Denys Chaigne; Jaume Colomer; Maria Luz Cuadrado; Marianne de Visser; Isabelle Desguerre; Bruno Eymard; Nathalie Goemans; Angela Kaindl; Emmanuelle Lagrue; Jürg Lütschg; Edoardo Malfatti; Michèle Mayer; Luciano Merlini; David Orlikowski; Ulrike Reuner; Mustafa A Salih; Beate Schlotter-Weigel; Mechthild Stoetter; Volker Straub; Haluk Topaloglu; J Andoni Urtizberea; Anneke van der Kooi; Ekkehard Wilichowski; Norma B Romero; Michel Fardeau; Carsten G Bönnemann; Brigitte Estournet; Pascale Richard; Susana Quijano-Roy; Ulrike Schara; Ana Ferreiro
Journal:  Neurology       Date:  2020-08-13       Impact factor: 9.910

Review 8.  Calcium and Redox Liaison: A Key Role of Selenoprotein N in Skeletal Muscle.

Authors:  Ester Zito; Ana Ferreiro
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

Review 9.  Daytime noninvasive ventilatory support for patients with ventilatory pump failure: a narrative review.

Authors:  Paolo Banfi; Paola Pierucci; Eleonora Volpato; Antonello Nicolini; Agata Lax; Dominique Robert; John Bach
Journal:  Multidiscip Respir Med       Date:  2019-11-30

Review 10.  Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences.

Authors:  Thuy-Hang Nguyen; Stephanie Conotte; Alexandra Belayew; Anne-Emilie Declèves; Alexandre Legrand; Alexandra Tassin
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.